The Biggest Patent filing case in the pharmaceutical history
Pfizer’s patent for Lipitor is about to reach its expiration. Lipitor, with its billions of annual sales, is no doubt the biggest blockbuster drug and we should not be surprised to know that the generic drug for Lipitor has already been patented! Lipitor will lose its patent rights in 2011. Arrow Group, a private drug selling company, was authorized by FDA to sell the generic version of Pfizer’s Lipitor in the U.S territory. But now Watson, one of the major U.S. pharmaceuticals, has bought the rights to sell the generic drug for Lipitor after for $1.7 billion.
Showing posts with label Generic Drug For Lipitor. Show all posts
Showing posts with label Generic Drug For Lipitor. Show all posts
Tuesday, August 25, 2009
Subscribe to:
Comments (Atom)